HARVARD BIOSCIENCE INC — Director's Dealing 2020

May 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-05-23

Reporting Person: Green James W (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-23	Common Stock	F	10302	$2.66	Disposed	1502143	Direct

Footnotes

F1: Includes (a) 202,875 restricted stock units that will fully vest on July 8, 2020; (b) 243,072 restricted stock units that will fully vest on July 8, 2021; (c) 313,770 restricted stock units that will vest in three equal installments on January 1, 2021, 2022 and 2023; (d) 418,360 restricted stock units with performance based vesting conditions tied to relative total shareholder return; and (e) 324,066 shares of common stock beneficially owned by the Reporting Person.